Last reviewed · How we verify

NCT07025187

the Effect of Integrated Neuomuscular Inhibition Technique on Adult Females With Cervicogenic Headache

Completed NA Last updated 18 November 2025
What this trial tests

NA trial testing Muscle relaxants tizanidine in Cervicogenic Headache in 40 participants. Completed in 1 November 2025.

Timeline
16 June 2025
Primary endpoint
1 November 2025
1 November 2025

Quick facts

Lead sponsorKafrelsheikh University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment40
Start date16 June 2025
Primary completion1 November 2025
Estimated completion1 November 2025
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Kafrelsheikh University

Who can join

Adults 18 to 60, female only, with Cervicogenic Headache. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the current study is investigating the effect of integrated neuromuscular inhibition technique on adult females with cervicogenic headache. Methods: Forty females with cervicogenic headache will be recruited. Patients will be randomly assigned into two groups, group A and group B . Patients in both groups will receive a traditional medical treatment, but group (B) will receive additional integrated neuromuscular inhibition technique.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Efficacy of integrated neuromuscular inhibition technique in women with cervicogenic headache: a double-blind randomized controlled trial.
    Karam M, El-Shamy FF, Elhosary EA, Mofreh A, et al · · 2026 · PMID 42237665 · DOI 10.1080/09593985.2026.2683245

Verify or expand the search:

Other recruiting trials for Cervicogenic Headache

Currently open trials in the same condition.

Other Kafrelsheikh University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07025187.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing